Contineum Therapeutics, Inc. (CTNM)

CIK 1855175 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Contineum Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20261440001950047-26-009206
Sep 8, 202640001628280-26-060962
Sep 1, 20261440001950047-26-008923
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003422
Aug 3, 20261440001950047-26-007517
Aug 3, 202640001628280-26-052031
Aug 3, 20261440001950047-26-007509
Jul 30, 20268-K0001628280-26-051051
Jul 30, 202610-Q0001628280-26-051054
Jul 27, 2026SCHEDULE 13G0002012383-26-002243
Jul 17, 2026SCHEDULE 13G/A0001104659-26-084693
Jul 13, 20268-K0001628280-26-048023
Jul 10, 202640001628280-26-047909
Jul 8, 202640001628280-26-047710
Jul 8, 20261440001950047-26-006968
Jul 2, 202640001628280-26-047058
Jul 1, 202640001628280-26-046653
Jul 1, 202640001628280-26-046654
Jul 1, 20261440001950047-26-006723
Jun 30, 20261440001950047-26-006664
Jun 30, 20261440001950047-26-006666
Jun 30, 20261440001950047-26-006667
Jun 26, 202640001628280-26-045845
Jun 26, 202640001628280-26-045833
Jun 26, 202640001628280-26-045839